AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
THE CHALLENGE OF DESIGNING CLINICAL-TRIALS FOR AIDS-RELATED KAPOSIS-SARCOMA
Authors: LITTLE RF PLUDA JM FEIGAL E YARCHOAN R
Citation: Rf. Little et al., THE CHALLENGE OF DESIGNING CLINICAL-TRIALS FOR AIDS-RELATED KAPOSIS-SARCOMA, Oncology, 12(6), 1998, pp. 871
PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA
Authors: WELLES L SAVILLE MW LIETZAU J PLUDA JM WYVILL KM FEUERSTEIN I FIGG WD LUSH R ODOM J WILSON WH FAJARDO MT HUMPHREY RW FEIGAL E TUCK D STEINBERG SM BRODER S YARCHOAN R
Citation: L. Welles et al., PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(3), 1998, pp. 1112-1121
PHASE-I STUDY OF BRYOSTATIN-1 IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: VARTERASIAN ML MOHAMMAD RM EILENDER DS HULBURD K RODRIGUEZ DH PEMBERTON PA PLUDA JM DAN MD PETTIT GR CHEN BDM ALKATIB AM
Citation: Ml. Varterasian et al., PHASE-I STUDY OF BRYOSTATIN-1 IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 16(1), 1998, pp. 56-62
A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)
Authors: PLUDA JM WYVILL KK LIETZAU J FIGG WD WHITCUP SM FEIGAL E HUMPHREY R WELLES L YARCHOAN R
Citation: Jm. Pluda et al., A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 13-13
TUMOR-ASSOCIATED ANGIOGENESIS - PATHOGENESIS AND CLINICAL IMPLICATIONS
Authors: PLUDA JM
Citation: Jm. Pluda, TUMOR-ASSOCIATED ANGIOGENESIS - PATHOGENESIS AND CLINICAL IMPLICATIONS, European journal of cancer, 33, 1997, pp. 105-105
NEW DRUGS IN NON-HODGKINS-LYMPHOMA
Authors: ARBUCK SG SORENSEN JM CHRISTIAN MC HO P PLUDA JM CHESON BD
Citation: Sg. Arbuck et al., NEW DRUGS IN NON-HODGKINS-LYMPHOMA, Annals of oncology, 8, 1997, pp. 119-128
THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR
Authors: FIGG WD PLUDA JM LUSH RM SAVILLE MW WYVILL K REED E YARCHOAN R
Citation: Wd. Figg et al., THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR, Pharmacotherapy, 17(1), 1997, pp. 91-97
EFFECT OF COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE ON NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYMPTOMATIC HIV DISEASE - ACOMPARISON OF SIMULTANEOUS AND ALTERNATING REGIMENS
Authors: BROUWERS P HENDRICKS M LIETZAU JA PLUDA JM MITSUYA H BRODER S YARCHOAN R
Citation: P. Brouwers et al., EFFECT OF COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE ON NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYMPTOMATIC HIV DISEASE - ACOMPARISON OF SIMULTANEOUS AND ALTERNATING REGIMENS, AIDS, 11(1), 1997, pp. 59-66
DEVELOPMENT OF ANGIOGENESIS INHIBITORS FOR CANCER-THERAPY
Authors: ECKHARDT SG PLUDA JM
Citation: Sg. Eckhardt et Jm. Pluda, DEVELOPMENT OF ANGIOGENESIS INHIBITORS FOR CANCER-THERAPY, Investigational new drugs, 15(1), 1997, pp. 1-3
TUMOR-ASSOCIATED ANGIOGENESIS - MECHANISMS, CLINICAL IMPLICATIONS, AND THERAPEUTIC STRATEGIES
Authors: PLUDA JM
Citation: Jm. Pluda, TUMOR-ASSOCIATED ANGIOGENESIS - MECHANISMS, CLINICAL IMPLICATIONS, AND THERAPEUTIC STRATEGIES, Seminars in oncology, 24(2), 1997, pp. 203-218
PROMISING NEW AGENTS UNDER DEVELOPMENT BY THE DIVISION OF CANCER-TREATMENT, DIAGNOSIS, AND CENTERS OF THE NATIONAL-CANCER-INSTITUTE
Authors: CHRISTIAN MC PLUDA JM HO PTC ARBUCK SG MURGO AJ SAUSVILLE EA
Citation: Mc. Christian et al., PROMISING NEW AGENTS UNDER DEVELOPMENT BY THE DIVISION OF CANCER-TREATMENT, DIAGNOSIS, AND CENTERS OF THE NATIONAL-CANCER-INSTITUTE, Seminars in oncology, 24(2), 1997, pp. 219-240
A PHASE-I STUDY OF PENTOSAN POLYSULFATE SODIUM IN PATIENTS WITH ADVANCED MALIGNANCIES
Authors: LUSH RM FIGG WD PLUDA JM BITTON R HEADLEE D KOHLER D REED E SARTOR O COOPER MR
Citation: Rm. Lush et al., A PHASE-I STUDY OF PENTOSAN POLYSULFATE SODIUM IN PATIENTS WITH ADVANCED MALIGNANCIES, Annals of oncology, 7(9), 1996, pp. 939-944
AIDS-RELATED KAPOSIS-SARCOMA - A TEMPLATE FOR THE TRANSLATION OF MOLECULAR PATHOGENESIS AND TARGETED THERAPEUTIC APPROACHES
Authors: KARP JE PLUDA JM YARCHOAN R
Citation: Je. Karp et al., AIDS-RELATED KAPOSIS-SARCOMA - A TEMPLATE FOR THE TRANSLATION OF MOLECULAR PATHOGENESIS AND TARGETED THERAPEUTIC APPROACHES, Hematology/oncology clinics of North America, 10(5), 1996, pp. 1031
CLINICAL IMPLICATIONS OF TUMOR-ASSOCIATED NEOVASCULARIZATION AND CURRENT ANTIANGIOGENIC STRATEGIES FOR THE TREATMENT OF MALIGNANCIES OF PANCREAS
Authors: PLUDA JM PARKINSON DR
Citation: Jm. Pluda et Dr. Parkinson, CLINICAL IMPLICATIONS OF TUMOR-ASSOCIATED NEOVASCULARIZATION AND CURRENT ANTIANGIOGENIC STRATEGIES FOR THE TREATMENT OF MALIGNANCIES OF PANCREAS, Cancer, 78(3), 1996, pp. 680-687
ACTIVITY OF PACLITAXEL (TAXOL(TM)) FOR THE TREATMENT OF HIV-ASSOCIATED KAPOSIS SARCOMA (KS)
Authors: SAVILLE MW LIETZAU J PLUDA JM WILSON W FEIGAL E FEUERSTEIN I ODOM J HUMPHREY R BRODER S YARCHOAN R
Citation: Mw. Saville et al., ACTIVITY OF PACLITAXEL (TAXOL(TM)) FOR THE TREATMENT OF HIV-ASSOCIATED KAPOSIS SARCOMA (KS), AIDS research and human retroviruses, 11, 1995, pp. 77-77
PHASE I II STUDY OF INTERMITTENT ALL-TRANS-RETINOIC ACID, ALONE AND IN COMBINATION WITH INTERFERON ALFA-2A, IN PATIENTS WITH EPIDEMIC KAPOSIS-SARCOMA/
Authors: BAILEY J PLUDA JM FOLI A SAVILLE MW BAUZA S ADAMSON PC MURPHY RF COHEN RB BRODER S YARCHOAN R
Citation: J. Bailey et al., PHASE I II STUDY OF INTERMITTENT ALL-TRANS-RETINOIC ACID, ALONE AND IN COMBINATION WITH INTERFERON ALFA-2A, IN PATIENTS WITH EPIDEMIC KAPOSIS-SARCOMA/, Journal of clinical oncology, 13(8), 1995, pp. 1966-1974
GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HIV-1 ISOLATED FROM PATIENTS RECEIVING (-)-2',3'-DIDEOXY-3'-THIACYTIDINE
Authors: KAVLICK MF SHIRASAKA T KOJIMA E PLUDA JM HUI F YARCHOAN R MITSUYA H
Citation: Mf. Kavlick et al., GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HIV-1 ISOLATED FROM PATIENTS RECEIVING (-)-2',3'-DIDEOXY-3'-THIACYTIDINE, Antiviral research, 28(2), 1995, pp. 133-146
TREATMENT OF HIV-ASSOCIATED KAPOSIS-SARCOMA WITH PACLITAXEL
Authors: SAVILLE MW LIETZAU J PLUDA JM FEUERSTEIN I ODOM J WILSON WH HUMPHREY RW FEIGAL E STEINBERG SM BRODER S YARCHOAN R
Citation: Mw. Saville et al., TREATMENT OF HIV-ASSOCIATED KAPOSIS-SARCOMA WITH PACLITAXEL, Lancet, 346(8966), 1995, pp. 26-28
A PHASE I II STUDY OF 2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
Authors: PLUDA JM COOLEY TP MONTANER JSG SHAY LE REINHALTER NE WARTHAN SN RUEDY J HIRST HM VICARY CA QUINN JB YUEN GJ WAINBERG MA RUBIN M YARCHOAN R
Citation: Jm. Pluda et al., A PHASE I II STUDY OF 2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, The Journal of infectious diseases, 171(6), 1995, pp. 1438-1447
5-YEAR FOLLOW-UP OF A PHASE-I STUDY OF DIDANOSINE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: NGUYEN BY YARCHOAN R WYVILL KM VENZON DJ PLUDA JM MITSUYA H BRODER S
Citation: By. Nguyen et al., 5-YEAR FOLLOW-UP OF A PHASE-I STUDY OF DIDANOSINE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 171(5), 1995, pp. 1180-1189
ASSAY OF THE ANTIANGIOGENIC COMPOUND TNP-470, AND ONE OF ITS METABOLITES, AGM-1883, BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY IN PLASMA
Authors: FIGG WD YEH HJC THIBAULT A PLUDA JM ITOH F YARCHOAN R COOPER MR
Citation: Wd. Figg et al., ASSAY OF THE ANTIANGIOGENIC COMPOUND TNP-470, AND ONE OF ITS METABOLITES, AGM-1883, BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY IN PLASMA, Journal of chromatography B. Biomedical applications, 652(2), 1994, pp. 187-194
CLINICAL DEVELOPMENT OF ANTICANCER AGENTS FROM NATURAL-PRODUCTS
Authors: PARKINSON DR ARBUCK SG MOORE T PLUDA JM CHRISTIAN MC
Citation: Dr. Parkinson et al., CLINICAL DEVELOPMENT OF ANTICANCER AGENTS FROM NATURAL-PRODUCTS, Stem cells, 12(1), 1994, pp. 30-43
APPROACHES TO THE DEVELOPMENT OF THERAPY FOR KAPOSISS SARCOMA (KS) - A REPORT ON ONGOING STUDIES
Authors: YARCHOAN R SAVILLE MW PLUDA JM FOLI A BAILEY J WILSON W BRODER S
Citation: R. Yarchoan et al., APPROACHES TO THE DEVELOPMENT OF THERAPY FOR KAPOSISS SARCOMA (KS) - A REPORT ON ONGOING STUDIES, AIDS research and human retroviruses, 10, 1994, pp. 190000052-190000052
A RANDOMIZED PILOT-STUDY OF ALTERNATING OR SIMULTANEOUS ZIDOVUDINE AND DIDANOSINE THERAPY IN PATIENTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: YARCHOAN R LIETZAU JA NGUYEN BY BRAWLEY OW PLUDA JM SAVILLE MW WYVILL KM STEINBERG SM AGBARIA R MITSUYA H BRODER S
Citation: R. Yarchoan et al., A RANDOMIZED PILOT-STUDY OF ALTERNATING OR SIMULTANEOUS ZIDOVUDINE AND DIDANOSINE THERAPY IN PATIENTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 169(1), 1994, pp. 9-17
THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR
Authors: FIGG WD PLUDA JM WYVILL K SAVILLE W THIBAULT A MCCALL NA SOGOCIO T REED E BRODER S YARCHOAN R
Citation: Wd. Figg et al., THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR, Clinical research, 42(2), 1994, pp. 10000253-10000253
Risultati: 1-25 | 26-32